ebb^® Complete Tamponade System: effective hemostasis for postpartum hemorrhage

Abstract

As a leading cause of maternal death, postpartum hemorrhage (PPH) remains a worldwide obstetrical problem. However, in most cases, mortality and morbidity can be averted if efforts are immediately undertaken to achieve hemostasis. Uterine balloon tamponade has been shown to provide effective control of PPH and avoid more invasive surgical procedures and even the emergency peripartum hysterectomy. Recent clinical recommendation suggests that balloon tamponade should be considered earlier in the treatment cascade in conjunction with uterotonic agents to ensure hemostasis in the most timely fashion and maximize clinical outcomes. This paper profiles the ebb® Complete Tamponade System, a unique dual-balloon single-use device that was developed specifically for hemostatic management of PPH. The ebb system combines a uterine conforming balloon that can be rapidly deployed with a vaginal balloon that eliminates the need for vaginal packing. The description, indications for use, procedural steps, and clinical characterization of this device are presented.

Mechanical Properties of the Every Second Matters for Mothers-Uterine Balloon Tamponade (ESM-UBT) Device: In Vitro Tests

“…8 11 More recently, balloon tamponade devices have been specifically designed for intrauterine application, such as the BT-Cath, the ebb Complete Tamponade System (ebb), the Rusch UBT, and the Bakri postpartum balloon catheter (Bakri) among others. 12 13 14 15 16 17 18 While reports on patient outcomes associated with commercial UBT devices are encouraging, their high cost (up to $ 400 USD) is a barrier to implementation across resource-poor settings. 13…”